A promising new therapy, the FDA approval of Lipfendra, and updated cholesterol guidelines are expanding treatment options ...

Updated cholesterol guidelines could make more than half of adults ages 30 to 79 in the United States eligible for statins.

"Two independent laboratories found the same compounds falling in the plasma." ...

New cholesterol guidelines advise doctors to begin screening and treating people in their 30s, long before the risks of a heart attack and stroke become significantly higher. For the first time, the ...

The Food and Drug Administration approved a drug earlier this month that may change how high cholesterol is treated.

Lipfendra, the first once-daily oral PCSK9 inhibitor, was shown to reduce LDL cholesterol by roughly 56% to 60% when combined with statins.

The US Food and Drug Administration has approved Lipfendra, scientifically known as enlicitide, as the first oral medicine de ...

Amelia MacIntyre, DO, is a board-certified family medicine physician. She is certified in osteopathic medicine. Whole plant foods, soluble fiber, and unsaturated fats can help lower LDL cholesterol.

A new FDA-approved cholesterol drug replaces injectable treatments with a daily pill—and experts say it delivers powerful results.

Current treatments such as targeted drugs and immunotherapy have limited success, providing only temporary relief for some patients. For patients with advanced liver cancer, especially those with ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

A University of Oklahoma researcher has received a five-year, $2 million grant from the National Cancer Institute to ...